captopril has been researched along with mannitol in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benz, RL; Gilgore, GS; Schleifer, CR; Sigler, MH; Teehan, BP | 1 |
| Anaise, D; Lane, B; Rapaport, FT; Waltzer, WC | 1 |
| Denton, DA; Di Nicolantonio, R; McKinley, MJ; Muller, AF; Tarjan, E; Weisinger, RS | 1 |
| Bosman, H; Dormehl, I; Hordijk, C; Hugo, N; Maree, M; Pilloy, W | 1 |
| Iwata, H; Ochi, K; Takeuchi, M; Yokoyama, M | 1 |
| Appelgren, B; Eriksson, S; Jónasson, H; Rundgren, M | 1 |
| Demiryürek, AT; Kane, KA; Wadsworth, RM; Wainwright, CL | 1 |
| Hu, P; Sinko, PJ | 1 |
| Davis, K; Fabian, E; Greenhaw, J; Groeters, S; Herold, M; Kamp, H; Looser, R; Marxfeld, H; Mattes, W; Mellert, W; Moeller, N; Montoya-Parra, G; Prokoudine, A; Strauss, V; van Ravenzwaay, B; Walk, T | 1 |
| Dhein, S; Hoyer, A; Kempfert, J; Mohr, FW; Pritzwald-Stegmann, P | 1 |
| Brniak, W; Loskot, J; Mužíková, J; Navrátil, O; Tranová, T | 1 |
1 review(s) available for captopril and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for captopril and mannitol
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Suppression of renal vein renin profiles by mannitol prophylaxis: implications in the evaluation of renovascular hypertension.
Topics: Adult; Aged; Captopril; Female; Humans; Hypertension, Renovascular; Male; Mannitol; Middle Aged; Radiography; Renal Artery; Renal Veins; Renin | 1991 |
The protective effect of calcium inhibitors and of captopril on the renal microcirculation during reperfusion.
Topics: Angiotensin II; Animals; Calcium; Captopril; Dogs; Heparin; Kidney; Kidney Cortex; Kidney Glomerulus; Kidney Transplantation; Mannitol; Microcirculation; Organ Preservation; Perfusion; Trifluoperazine; Verapamil | 1987 |
Role of angiotensin in sodium appetite of sodium-deplete sheep.
Topics: Angiotensin II; Animals; Captopril; Injections, Intravenous; Injections, Intraventricular; Mannitol; Natriuresis; Osmolar Concentration; Renin; Saliva; Sheep; Sodium | 1987 |
Evaluation of the clinical validity of the "integral spleen" method of renography analysis from parameter changes induced by pharmacological and surgical intervention.
Topics: Animals; Captopril; Constriction; Furosemide; Glomerular Filtration Rate; Kidney; Male; Mannitol; Organometallic Compounds; Papio; Pentetic Acid; Radioisotope Renography; Renal Artery Obstruction; Spleen; Technetium; Technetium Tc 99m Pentetate | 1988 |
Pharmacological enhancement of recovery in experimental hydronephrosis.
Topics: Animals; Captopril; Furosemide; Hydronephrosis; Indomethacin; Inosine; Kidney; Kidney Cortex; Kidney Medulla; Male; Mannitol; Methylprednisolone; Rats; Rats, Inbred Strains | 1985 |
Drinking in goats as effect of simultaneous intravenous infusions of angiotensin (I or II) and hypertonic NaCl or mannitol.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Captopril; Drinking; Female; Goats; Infusions, Parenteral; Male; Mannitol; Saline Solution, Hypertonic; Sodium Chloride | 1981 |
Characterization of a method for the detection of drugs with free radical scavenging activity using porcine leukocytes.
Topics: Animals; Antioxidants; Azides; Captopril; Catalase; Drug Evaluation, Preclinical; Free Radical Scavengers; Ionomycin; Leukocytes; Luminescent Measurements; Mannitol; Sodium Azide; Superoxide Dismutase; Swine; Tetradecanoylphorbol Acetate; Xanthine; Xanthine Oxidase; Xanthines | 1994 |
Determination intestinal metabolism and permeability for several compounds in rats. Implications on regional bioavailability in humans.
Topics: Animals; Biological Availability; Captopril; Didanosine; Humans; Intestine, Small; Male; Mannitol; Ofloxacin; Permeability; Rats; Rats, Sprague-Dawley; Zidovudine | 1996 |
Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
Topics: Animals; Atropine; Captopril; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Flutamide; Lamivudine; Liver; Male; Mannitol; Metabolomics; Methotrexate; Neomycin; Oxidative Stress; Phenytoin; Piperazines; Propylthiouracil; Rats; Rats, Wistar; Streptomycin; Triazoles; Valproic Acid; Vancomycin; Zidovudine | 2014 |
Acute hemodynamic effects of angiotensin- converting enzyme inhibition after prolonged cardiac arrest with Bretschneider's solution.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelin Receptor Antagonists; Glucose; Heart Arrest; Hemodynamics; Losartan; Male; Malondialdehyde; Mannitol; Myocardial Reperfusion Injury; Oxygen Consumption; Peptides, Cyclic; Potassium Chloride; Procaine; Rabbits | 2014 |
Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.
Topics: Administration, Oral; Captopril; Domperidone; Drug Compounding; Excipients; Mannitol; Solubility; Tablets; Tramadol | 2023 |